# Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart Disease

> **NCT00552747** · PHASE4 · COMPLETED · sponsor: **National Heart Institute, Mexico** · enrollment: 76 (actual)

## Conditions studied

- Coronary Heart Disease
- Hyperlipidemia

## Interventions

- **DRUG:** fenofibrate
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00552747
- **Lead sponsor:** National Heart Institute, Mexico
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2010-03
- **Final completion:** 2011-01
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2011-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00552747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00552747, "Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart Disease". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00552747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*